Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Leukemia, acute myeloid (AML), adult
Trial Status:  Active
Results 1-25 of 672 for your search:
Start Over
Efficacy of G-CSF-Priming in Elderly AML Patients
Phase: Phase IV
Type: Treatment
Status: Active
Age: Over 60
Sponsor: Other
Protocol IDs: AML-elderly 01/99 Trial, NCT00199147
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia
Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: MK1-192, NCT00180128
Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 30052004, NCT00196768
Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H0901329, NCT01189409
Paracetamol for Cancer Pain
Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: Par 06-0045, NCT01313247
Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: PI2011-843-0005, NCT01819792
Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 40 to 60
Sponsor: Other
Protocol IDs: 2013-08, NCT01856803
A Rollover Study to Provide Continued Treatment With Eltrombopag
Phase: Phase IV
Type: Natural history/Epidemiology
Status: Active
Age: 1 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 200170, NCT01957176
Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: APL2012, NCT01987297
AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: CHXY-AML01, NCT02024308
Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT
Phase: Phase IV
Type: Treatment
Status: Active
Age: 65 and younger
Sponsor: Other
Protocol IDs: PUPH IRB [2013](38), NCT02027064
Observational Trial of a Therapeutic Platelet Transfusion Regimen
Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 to 60
Sponsor: Other
Protocol IDs: 001, NCT02276651
Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)
Phase: Phase IV
Type: Diagnostic, Supportive care
Status: Approved-not yet active
Age: 16 to 80
Sponsor: Other
Protocol IDs: PLPH, NCT02347878
Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 61 and over
Sponsor: Other
Protocol IDs: EORTC-06031, NCT00091234
Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: IAPLSG2004, BT/PR4460/Med/14/531/2003, NCT00517712
Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: MT2006-13, 0607M89052, UMN-MT2006-13, NCT00630565
Unrelated Double Umbilical Cord Blood Units Transplantation
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 1 to 50
Sponsor: Other
Protocol IDs: HORCSCT-0902, NCT01015742
Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H-4-2010-046, NCT01404520
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: J1227, NA_00071844, NCT01588951
Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: Busulfan-2013, NCT01800643
MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: MSC-CY-Russia, NCT02270307
Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 17 to 64
Sponsor: Other
Protocol IDs: CHSCTC-R02-DeGREE, NCT02427919
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20040212, UCLA-0412042-01, AMGEN-20040212, NCT00109031
Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia
Phase: Phase III
Type: Treatment
Status: Active
Age: 35 to 55
Sponsor: Other
Protocol IDs: P040420, AOM04088, NCT00224614
Start Over